Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid

Bioanalysis
Niels KruseBrit Mollenhauer

Abstract

α-Synuclein (aSyn), a putative cerebrospinal fluid biomarker, may support the diagnosis of neurodegenerative diseases. Previous studies led to conflicting results due to different preanalytical and analytical procedures. Standardized assays are required to allow for comparison of results from different laboratories. We performed a side-by-side validation of a commercially available (MSD, MD, USA) and a 'homebrew' assay for quantification of aSyn according to published guidelines. The data showed high sensitivity and reproducibility for both assays. Preanalytical and analytical parameters did not affect the outcome of measurements. We conclude that both assays are very close in performance and suitable for research application of cerebrospinal fluid aSyn.

References

Jan 7, 2006·Pharmaceutical Research·Jean W LeeJohn A Wagner
Mar 21, 2008·Molecular & Cellular Proteomics : MCP·Zhiyin XunDavid E Clemmer
Aug 24, 2013·Molecular & Cellular Proteomics : MCP·Adrien W SchmidHilal A Lashuel
May 23, 2014·Journal of the American Society for Mass Spectrometry·Stefan SlamnoiuMichael Przybylski
Aug 19, 2014·PloS One·Valerie JoersMarina E Emborg
Oct 28, 2014·The European Journal of Neuroscience·Alicia Flores-CuadradoAlino Martinez-Marcos
Sep 9, 2015·Frontiers in Neurology·Ulf AndreassonCharlotte E Teunissen

❮ Previous
Next ❯

Citations

Nov 8, 2018·Journal of Parkinson's Disease·Kalpana M MerchantUNKNOWN and The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISAs
light microscopy
size-exclusion chromatography
ELISA
PCR

Software Mentioned

Workbench
Excel
Hemastix

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.